{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:14:28Z","timestamp":1758402868641},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Swedish Foundation for Strategic Research"},{"name":"The Swedish Heart-Lung Foundation"},{"name":"Loo and Hans Ostermans foundation"},{"name":"The Swedish Twin Registry"},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["LSHM-CT-2006-037227"],"award-info":[{"award-number":["LSHM-CT-2006-037227"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.atherosclerosis.2011.04.038","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T01:14:18Z","timestamp":1304817258000},"page":"117-122","source":"Crossref","is-referenced-by-count":13,"title":["Genetic and environmental regulation of inflammatory CVD biomarkers Lp-PLA2 and IgM anti-PC"],"prefix":"10.1016","volume":"218","author":[{"given":"Iffat","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajai","family":"Atout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"de Faire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Frosteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Ninio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Bennet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik K.E.","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0005","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm1102-1211","article-title":"Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime","volume":"8","author":"Steinberg","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/HCO.0b013e32832bcb22","article-title":"Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target","volume":"24","author":"Packard","year":"2009","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0015","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1016\/S0021-9258(18)83548-7","article-title":"An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma","volume":"264","author":"Stremler","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0020","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/hmg\/ddh145","article-title":"Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease","volume":"13","author":"Ninio","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.0000154553.12214.CD","article-title":"Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study","volume":"111","author":"Oei","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0030","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/ATVBAHA.107.142679","article-title":"Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects","volume":"27","author":"Persson","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0035","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1161\/ATVBAHA.107.151670","article-title":"Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease","volume":"27","author":"Sabatine","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/eurheartj\/ehn502","article-title":"Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study","volume":"30","author":"Tsimikas","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0045","doi-asserted-by":"crossref","unstructured":"Thompson A, Gao P, Orfei L, et al. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet, 375:1536\u20131544.","DOI":"10.1016\/S0140-6736(10)60319-4"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0050","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/S0022-2275(20)34942-7","article-title":"Determinants of plasma platelet-activating factor acetylhydrolase: heritability and relationship to plasma lipoproteins","volume":"38","author":"Guerra","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1476-511X-8-19","article-title":"Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults","volume":"8","author":"Detopoulou","year":"2009","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2008.08.045","article-title":"A twin study of heritability of plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) mass and activity","volume":"205","author":"Lenzini","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2005.10.017","article-title":"Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension","volume":"188","author":"Su","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0070","doi-asserted-by":"crossref","unstructured":"Fiskesund R, Stegmayr B, Hallmans G, et al. Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden. Stroke, 41:607\u2013612.","DOI":"10.1161\/STROKEAHA.109.558742"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/HJR.0b013e32832a05df","article-title":"Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden","volume":"16","author":"Gronlund","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0080","article-title":"Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism","author":"de Faire","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0085","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/rheumatology\/ken120","article-title":"Natural antibodies against phosphorylcholine as potential protective factors in SLE","volume":"47","author":"Su","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0090","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL","volume":"9","author":"Binder","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1365-2796.2002.01032.x","article-title":"The Swedish twin registry: a unique resource for clinical, epidemiological and genetic studies","volume":"252","author":"Lichtenstein","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0100","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/01.ATV.15.10.1764","article-title":"PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme","volume":"15","author":"Tselepis","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1375\/twin.12.3.286","article-title":"Genetic dominance influences blood biomarker levels in a sample of 12,000 Swedish elderly twins","volume":"12","author":"Rahman","year":"2009","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0110","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0736-4679(99)00135-3","article-title":"The C-reactive protein","volume":"17","author":"Clyne","year":"1999","journal-title":"J Emerg Med"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0115","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.0000160551.21962.a7","article-title":"Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target","volume":"25","author":"Zalewski","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0120","series-title":"Mx: statistical modeling","author":"Neale","year":"2006"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0125","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.atherosclerosis.2007.07.014","article-title":"A pleiotropic QTL on 2p influences serum Lp-PLA2 activity and LDL cholesterol concentration in a baboon model for the genetics of atherosclerosis risk factors","volume":"196","author":"Vinson","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0952-7915(99)00072-2","article-title":"Unique and unprecedented recombination mechanisms in class switching","volume":"12","author":"Kinoshita","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.molmed.2008.04.003","article-title":"Biomarkers for cardiovascular disease: challenges and future directions","volume":"14","author":"May","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.atherosclerosis.2011.04.038_bib0140","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011003844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011003844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T22:16:53Z","timestamp":1637619413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011003844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0021915011003844"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.04.038","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}